Weight/Heart/Women

Berberine

Plant alkaloid that lowers blood sugar and improves lipids in people with insulin resistance or type 2 diabetes.

Berberine

Berberine

67
score
B
evidence
Caution
risk

Proven Benefits

01Reduces fasting glucose/HbA1c
02Lowers LDL and triglycerides
03Improves fatty liver markers
04Supports modest weight loss
05Reduces CRP and inflammation
06Improves PCOS symptoms
07May lower blood pressure

Chemical Forms

Recommended
  • Berberine HCl
  • Dihydroberberine
Avoid
  • Berberine sulfate (less studied, uncommon)
  • Unstandardized barberry/goldenseal powders (variable alkaloid content)
Expert Note

Berberine HCl is the best-studied form in human trials. Dihydroberberine may be better absorbed and sometimes better tolerated, but comparative data are smaller. Unstandardized plant powders are harder to dose consistently and often deliver far less active alkaloid.

Protocol

Amount
1000-1500 mg
Frequency
Split into 2-3 doses daily
When
With or 15-30 minutes before meals; take with food if it causes GI upset.

Condition-Based Dosing

Prediabetes or type 2 diabetes
500 mg three times daily for 8-12 weeks
Elevated LDL cholesterol, triglycerides, or metabolic syndrome
500 mg two to three times daily for 12 weeks
Adults with fatty liver or elevated ALT
500 mg two to three times daily for 12 weeks
Women with PCOS and insulin resistance
500 mg two to three times daily for 12-16 weeks

Safety & Limits

Upper Safe Limit
1500 mg/day (typical studied dose; no official UL established)
Cycling
Safe for continuous use

Contraindications

Pregnancy or breastfeeding — insufficient safety data; avoid unless prescribed
Neonates or infants — bilirubin displacement risk
Insulin, sulfonylureas, or other glucose-lowering drugs — additive hypoglycemia
Narrow-therapeutic-index drugs metabolized by CYP/P-gp (e.g., warfarin, cyclosporine, some antiarrhythmics) — interaction risk

Synergies

Omega-3 complements berberine’s triglyceride-lowering and cardiometabolic effects.

Magnesium is a cofactor in glucose metabolism; deficiency can blunt insulin sensitivity improvements.

Both improve insulin signaling and have been studied together for PCOS and metabolic syndrome.

Avoid Combining With

  • High-sugar/refined-carb diet (blunts glucose-lowering effect)
  • CYP/P-gp inducer drugs like rifampin or St. John's wort (may lower exposure)
  • Alcohol (can worsen GI tolerance and glycemic swings)
Updated Invalid Date